ArticleFrontiers in microbiology2018
Molecular Characteristics of Community-Associated
Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 51 citations in OpenAlex.
- Article
- Genomic and phenotypic adaptations of methicillin resistant Staphylococcus aureus during vancomycin therapy.Scientific reports · 2025Article
- Distribution ofFrontiers in cellular and infection microbiology · 2025Article
- Antimicrobial susceptibility profiles of invasive bacterial infections among children from low- and middle-income countries in the Western Pacific Region (WPRO) - a systematic review and meta-analysis.The Lancet regional health. Western Pacific · 2024Article
- Prevalence and Phage-Based Biocontrol of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2024Article
- High prevalence of ST5-SCCmec II-t311 clone of methicillin-resistant Staphylococcus aureus isolated from bloodstream infections in East China.BMC microbiology · 2024Article
- Virulence attributes of successful methicillin-resistantClinical microbiology reviews · 2023Review
- Molecular Epidemiology of Bulgarian Clinically SignificantPolish journal of microbiology · 2023Article
- Characterisation of aPathogens (Basel, Switzerland) · 2023Article
- Antimicrobial Usage and Detection of Multidrug-ResistantAntibiotics (Basel, Switzerland) · 2023Article
- Resistance and Molecular Characteristics of Methicillin-ResistantInfection and drug resistance · 2023Article
- Epidemiology and Risk Factors of Community-Associated Bloodstream Infections in Zhejiang Province, China, 2017-2020.Infection and drug resistance · 2023Article
- Molecular typing and characterization ofFrontiers in microbiology · 2023Article
- Genomic epidemiology and characterization ofFrontiers in microbiology · 2023Article
- Virulence adaption to environment promotes the age-dependent nasal colonization ofEmerging microbes & infections · 2022Article
- Methicillin-resistantEmerging microbes & infections · 2022Article
- Identification of methicillin-resistantEmerging microbes & infections · 2022Article
- The prevalence of virulence determinants in methicillin-resistant Staphylococcus aureus isolated from different infections in hospitalized patients in Poland.Scientific reports · 2022Article
- Multi-site infection by methicillin-resistant Staphylococcus aureus in a six-year old girl: a case report.BMC infectious diseases · 2022Article
- Comparison of Genetic Features and Evolution of Global and Chinese Strains of Community-Associated Methicillin-Resistant Staphylococcus aureus ST22.Microbiology spectrum · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.